These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 16453186)

  • 1. Prognostic factors for progression of visual field damage in patients with normal-tension glaucoma.
    Nakagami T; Yamazaki Y; Hayamizu F
    Jpn J Ophthalmol; 2006; 50(1):38-43. PubMed ID: 16453186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of progression of visual field damage to postural changes in intraocular pressure in patients with normal-tension glaucoma.
    Kiuchi T; Motoyama Y; Oshika T
    Ophthalmology; 2006 Dec; 113(12):2150-5. PubMed ID: 16996611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study.
    Caprioli J; Coleman AL
    Ophthalmology; 2008 Jul; 115(7):1123-1129.e3. PubMed ID: 18082889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression of visual field in patients with primary open-angle glaucoma - ProgF study 1.
    Aptel F; Aryal-Charles N; Giraud JM; El Chehab H; Delbarre M; Chiquet C; Romanet JP; Renard JP
    Acta Ophthalmol; 2015 Dec; 93(8):e615-20. PubMed ID: 26095771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contributing factors for progression of visual field loss in normal-tension glaucoma patients with medical treatment.
    Sakata R; Aihara M; Murata H; Mayama C; Tomidokoro A; Iwase A; Araie M
    J Glaucoma; 2013 Mar; 22(3):250-4. PubMed ID: 23059475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between intraocular pressure and rate of visual field progression in treated glaucoma.
    Rao HL; Addepalli UK; Jonnadula GB; Kumbar T; Senthil S; Garudadri CS
    J Glaucoma; 2013 Dec; 22(9):719-24. PubMed ID: 22595936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between the mean deviation slope and follow-up intraocular pressure in open-angle glaucoma patients.
    Fukuchi T; Yoshino T; Sawada H; Seki M; Togano T; Tanaka T; Ueda J; Abe H
    J Glaucoma; 2013 Dec; 22(9):689-97. PubMed ID: 23722866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of visual field progression in medically treated normal-tension glaucoma patients with unstable ocular perfusion pressure.
    Sung KR; Cho JW; Lee S; Yun SC; Choi J; Na JH; Lee Y; Kook MS
    Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):737-43. PubMed ID: 20861474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of ocular hypotensive medications in preventing the progression of visual field damage in patients with normal-tension glaucoma].
    Nakagami T; Yamazaki Y; Hayamizu F; Tanaka C
    Nippon Ganka Gakkai Zasshi; 2004 Jul; 108(7):408-14. PubMed ID: 15359903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study.
    Martínez A; Sánchez M
    Clin Ther; 2008 Jun; 30(6):1120-34. PubMed ID: 18640468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history of open-angle glaucoma.
    Heijl A; Bengtsson B; Hyman L; Leske MC;
    Ophthalmology; 2009 Dec; 116(12):2271-6. PubMed ID: 19854514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between severity of visual field loss at presentation and rate of visual field progression in glaucoma.
    Rao HL; Kumar AU; Babu JG; Senthil S; Garudadri CS
    Ophthalmology; 2011 Feb; 118(2):249-53. PubMed ID: 20728941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial.
    Bengtsson B; Leske MC; Hyman L; Heijl A;
    Ophthalmology; 2007 Feb; 114(2):205-9. PubMed ID: 17097736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visual Field Change and 24-Hour IOP-Related Profile with a Contact Lens Sensor in Treated Glaucoma Patients.
    De Moraes CG; Jasien JV; Simon-Zoula S; Liebmann JM; Ritch R
    Ophthalmology; 2016 Apr; 123(4):744-53. PubMed ID: 26854032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors for progression of visual field damage in patients with normal-tension glaucoma.
    Spaeth GL
    Jpn J Ophthalmol; 2007; 51(2):156; author reply 156-7. PubMed ID: 17401633
    [No Abstract]   [Full Text] [Related]  

  • 16. Risk factors for visual field damage progression in normal-tension glaucoma eyes.
    Daugeliene L; Yamamoto T; Kitazawa Y
    Graefes Arch Clin Exp Ophthalmol; 1999 Feb; 237(2):105-8. PubMed ID: 9987625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors Associated with Loss of Visual Function in Medically Treated Advanced Normal Tension Glaucoma.
    Kim S; Sung KR
    Curr Eye Res; 2017 Mar; 42(3):429-435. PubMed ID: 27420769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical factors associated with progression of normal-tension glaucoma.
    Ishida K; Yamamoto T; Kitazawa Y
    J Glaucoma; 1998 Dec; 7(6):372-7. PubMed ID: 9871858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relation between intraocular pressure peak in the water drinking test and visual field progression in glaucoma.
    Susanna R; Vessani RM; Sakata L; Zacarias LC; Hatanaka M
    Br J Ophthalmol; 2005 Oct; 89(10):1298-301. PubMed ID: 16170120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of intraocular pressure reduction on perimetric variability in glaucomatous eyes.
    Fogagnolo P; McNaught A; Centofanti M; Rossetti L; Orzalesi N
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4557-63. PubMed ID: 17898278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.